Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial

OBJECTIVE: Previous studies have shown additive weight loss when intensive behavioral therapy (IBT) was combined with weight‐loss medication. The present multisite study provides the first evaluation, in primary care, of the effect of the Centers for Medicare and Medicaid Services–based IBT benefit,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Obesity (Silver Spring)
Main Authors: Wadden, Thomas A., Tronieri, Jena Shaw, Sugimoto, Danny, Lund, Michael Taulo, Auerbach, Pernille, Jensen, Camilla, Rubino, Domenica
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065111/
https://ncbi.nlm.nih.gov/pubmed/32090517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22726
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados